MOVE
Movano Inc.
NASDAQ · Healthcare · Medical - Devices · US
$14.74
+2.93%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.4M | 433.0K | 1.0M | — | — |
| Cost of Revenue | 7.4M | 2.3M | 3.0M | 158.0K | 134.0K |
| Gross Profit | (3.0M) | (1.8M) | (2.0M) | (158.0K) | (134.0K) |
| Operating Expenses | |||||
| R&D Expense | 4.1M | 5.7M | 11.2M | 16.7M | 19.0M |
| SG&A Expense | 22.7M | 7.9M | 11.0M | 12.8M | 11.5M |
| General & Admin Expense | 8.6M | 7.6M | 10.7M | — | 1.9K |
| Selling & Marketing Expense | (38.0K) | 300.0K | 300.0K | — | 11.5M |
| Other Expenses | (2.7M) | — | — | — | — |
| Total Operating Expenses | 24.1M | 13.7M | 22.2M | 29.5M | 30.3M |
| Cost and Expenses | 31.5M | 15.9M | 25.2M | 29.7M | 30.5M |
| Operating Income (EBIT) | (27.1M) | (15.5M) | (24.2M) | (29.7M) | (30.5M) |
| Non-Operating | |||||
| Interest Income | 85.0K | 183.0K | 495.0K | 407.0K | 133.0K |
| Interest Expense | 3.3M | 3.0M | — | — | 133.0K |
| Net Interest Income | (3.2M) | (2.8M) | 495.0K | 407.0K | — |
| Other Non-Op Income/Expense | (564.0K) | (2.8M) | 495.0K | 407.0K | 133.0K |
| Non-Operating Income (excl Interest) | (108.0K) | (183.0K) | (495.0K) | (407.0K) | (133.0K) |
| EBT (Pre-Tax Income) | (27.6M) | (18.3M) | (23.7M) | (29.3M) | (30.3M) |
| Income Tax Expense | 20.0K | — | — | — | (133.0K) |
| Bottom Line | |||||
| Net Income | (27.7M) | (18.3M) | (23.7M) | (29.3M) | (30.2M) |
| Earnings from Cont. Ops | (27.7M) | (18.3M) | (23.7M) | (29.3M) | (30.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (27.8M) | (18.3M) | (23.7M) | (29.3M) | (30.3M) |
| Per Share | |||||
| Basic EPS | ($12.24) | ($0.27) | ($0.39) | ($0.63) | ($0.91) |
| Diluted EPS | ($12.24) | ($0.27) | ($0.39) | ($0.63) | ($0.91) |
| Revenue Per Share | $1.77 | $0.01 | $0.02 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 2.5M | 84.1M | 60.2M | 46.2M | 33.0M |
| Diluted Shares Outstanding | 2.5M | 84.1M | 60.2M | 46.2M | 33.0M |
| Profitability Metrics | |||||
| EBITDA | (23.1M) | (15.2M) | (23.6M) | (29.1M) | (30.2M) |
| D&A | 3.9M | 149.0K | 166.0K | 158.0K | 134.0K |
| EBIT | (27.0M) | (15.3M) | (23.7M) | (29.3M) | (30.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026